Hamdy FC - Search Results

1

iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer.

Rehman I, Evans CA, Glen A, Cross SS, Eaton CL, Down J, Pesce G, Phillips JT, Yen OS, Thalmann GN, Wright PC, Hamdy FC. Rehman I, et al. Among authors: hamdy fc. PLoS One. 2012;7(2):e30885. doi: 10.1371/journal.pone.0030885. Epub 2012 Feb 15. PLoS One. 2012. PMID: 22355332 Free PMC article.

2

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.

Holen I, Croucher PI, Hamdy FC, Eaton CL. Holen I, et al. Among authors: hamdy fc. Cancer Res. 2002 Mar 15;62(6):1619-23. Cancer Res. 2002. PMID: 11912131

3

The survival effect of prolactin on PC3 prostate cancer cells.

Ruffion A, Al-Sakkaf KA, Brown BL, Eaton CL, Hamdy FC, Dobson PR. Ruffion A, et al. Among authors: hamdy fc. Eur Urol. 2003 Mar;43(3):301-8. doi: 10.1016/s0302-2838(03)00038-1. Eur Urol. 2003. PMID: 12600435

4

Distinct patterns of microsatellite instability are seen in tumours of the urinary tract.

Catto JW, Azzouzi AR, Amira N, Rehman I, Feeley KM, Cross SS, Fromont G, Sibony M, Hamdy FC, Cussenot O, Meuth M. Catto JW, et al. Among authors: hamdy fc. Oncogene. 2003 Nov 27;22(54):8699-706. doi: 10.1038/sj.onc.1206964. Oncogene. 2003. PMID: 14647464

5

Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.

Eaton CL, Wells JM, Holen I, Croucher PI, Hamdy FC. Eaton CL, et al. Among authors: hamdy fc. Prostate. 2004 May 15;59(3):304-10. doi: 10.1002/pros.20016. Prostate. 2004. PMID: 15042606

6

Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.

Nyambo R, Cross N, Lippitt J, Holen I, Bryden G, Hamdy FC, Eaton CL. Nyambo R, et al. Among authors: hamdy fc. J Bone Miner Res. 2004 Oct;19(10):1712-21. doi: 10.1359/JBMR.040703. Epub 2004 Jul 7. J Bone Miner Res. 2004. PMID: 15355567 Free article.

7

Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.

Rehman I, Azzouzi AR, Cross SS, Deloulme JC, Catto JW, Wylde N, Larre S, Champigneuille J, Hamdy FC. Rehman I, et al. Among authors: hamdy fc. Hum Pathol. 2004 Nov;35(11):1385-91. doi: 10.1016/j.humpath.2004.07.015. Hum Pathol. 2004. PMID: 15668896

8

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.

Catto JW, Azzouzi AR, Rehman I, Feeley KM, Cross SS, Amira N, Fromont G, Sibony M, Cussenot O, Meuth M, Hamdy FC. Catto JW, et al. Among authors: hamdy fc. J Clin Oncol. 2005 May 1;23(13):2903-10. doi: 10.1200/JCO.2005.03.163. Epub 2005 Mar 7. J Clin Oncol. 2005. PMID: 15753461

9

Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.

Rehman I, Cross SS, Catto JW, Leiblich A, Mukherjee A, Azzouzi AR, Leung HY, Hamdy FC. Rehman I, et al. Among authors: hamdy fc. Prostate. 2005 Dec 1;65(4):322-30. doi: 10.1002/pros.20302. Prostate. 2005. PMID: 16015609

10

Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance.

Catto JW, Hartmann A, Stoehr R, Bolderson E, Rehman I, Rosario DJ, Hamdy FC, Meuth M. Catto JW, et al. Among authors: hamdy fc. J Urol. 2006 Jun;175(6):2323-30. doi: 10.1016/S0022-5347(06)00256-4. J Urol. 2006. PMID: 16697867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

466 results

Search Page

Filters